Emeprid

1 x 125 ml

Oral solution

Active substance

Metoclopramide (Metoclopramide hydrochloride) : 1 mg/ml

ATC code

QA03FA01 Metoclopramide

QA03FA Propulsives

QA03F Propulsives

QA03 Drugs for functional gastrointestinal disorders

QA Alimentary tract and metabolism

Species

Dogs and cats.

Indications

Symptomatic treatment of vomiting and reduced gastro-intestinal motility associated with gastritis, pyloric spasm, chronic nephritis and digestive intolerance to some drugs.

Dose to be administered and administration route

Oral use. Administer the product directly into the mouth.

0.5 to 1 mg of metoclopramide hydrochloride per kg of body weight per day administered as either:

2.5 to 5.0 mg/10 kg (equivalent to 2.5 to 5 ml/10 kg), twice daily

1.7 to 3.3 mg/10 kg (equivalent to 1.7 to 3.3 ml/10 kg), three times daily.

Oral administrations can be repeated with interval of 6 hours.

Adverse reactions

Dogs, cats:

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Agitation¹, Aggression¹, Vocalisation¹

Ataxia¹, Abnormal movement NOS¹, Tremor¹, Prostration¹

¹These observed extrapyramidal effects are transient and disappear when treatment is stopped.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also the last section ‘Contact details’ of the package leaflet